INTERNATIONAL PATENT: IMMUNOGEN SWITZERLAND GMBH FILES APPLICATION FOR "VASCONSTRICTORS FOR REDUCING OCULAR TOXICITY OF ANTIBODY-MAYTANSINOID CONJUGATES"

GENEVA, May 12 -- IMMUNOGEN SWITZERLAND GMBH (Baarerstrasse 146300 Zug) filed a patent application (PCT/IB2024/060836) for "VASCONSTRICTORS FOR REDUCING OCULAR TOXICITY OF ANTIBODY-MAYTANSINOID CONJUGATES" on Nov 02, 2024. With publication no. WO/2025/094146, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WESTIN, Eric (c/o ImmunoGen, Inc.1 N. Waukegan RoadNorth Chicago, IL 60064), ZWEIDLER-MCKAY, Patrick (c/o ImmunoGen, Inc.1 N. Waukegan RoadNorth Chicago, IL 60064), WARBINGTON, Alexandra (c/o ImmunoGen, Inc.1 N. Waukega...